Star Health and / Q4-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-05-15Back to STARHEALTHANDALLIEDINSUR

Revenue

₹6,259 Cr

verification pending

Revenue YoY

17%

reported change

EBITDA

Pending

latest reported figure

Source

bse pending

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q4 FY26: -42 · Positive source sentiment · 2026-05-15Q4 FY26-42-42
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Star Health delivered a strong operational turnaround in Q4 FY26, with fresh retail growth surging 38% YoY on an N basis and overall GWP reaching ₹6,259 crore (+17% YoY). Underwriting profit jumped 200% YoY to ₹186 crore, driven by a 270bps improvement in combined ratio to 95.7% and a 400bps reduction in loss ratio to 65.2%. The retail loss ratio improved for the third consecutive quarter, aided by disciplined pricing, portfolio recalibration, and enhanced fraud management. However, a ₹558 crore mark-to-market loss from equity market volatility dragged reported PAT to a loss of ₹42 crore. Management guided for sustained loss ratio improvement through continued price hikes and wellness initiatives, targeting a normalized ROE of 13.1%. Key risk: a resurgence in seasonal claims or higher medical inflation could pressure loss ratios.

Colored figures show movement against the previous available record.

Guidance to track

  • Management aims to grow agent count to 1 million within the next two years, adding ~1 lakh agents annually.
  • Star Health will maintain its strategy of annual price increases on all products, with no abnormal hikes expected.
  • Management expects loss ratios to continue improving due to pricing actions, wellness initiatives, and portfolio mix.

Risks flagged

  • A recurrence of vector-borne diseases or higher seasonal claims could pressure loss ratios, as seen in prior years.
  • Rising healthcare costs and claim severity may require higher-than-expected price hikes to maintain margins.
  • Non-compliance by other insurers with expense of management limits could create competitive distortions, though Star Health is compliant.

Key quotes

  • The green shoots of our operating turnaround in the previous quarters is now more pronounced in our underlying metrics.
  • We are not desperate to grow our market share at the cost of profits.
  • It's a combination of everything... the improvement has been across the renewal book and the fresh book.

Research modules

Go one layer deeper.